{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:20:20Z","timestamp":1759940420582},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"RVC"},{"name":"Heptagon"},{"name":"Wellcome Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.078","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T21:13:49Z","timestamp":1325366029000},"page":"1702-1709","source":"Crossref","is-referenced-by-count":7,"title":["A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker"],"prefix":"10.1016","volume":"30","author":[{"given":"Laila M.R.","family":"El-Attar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.12.078_bib0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0010","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erv.10.57","article-title":"DNA vaccines for targeting bacterial infections","volume":"9","author":"Ingolotti","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/gt.2009.31","article-title":"Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects","volume":"16","author":"Chen","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00023210-200822030-00001","article-title":"Vaccines for multiple sclerosis: progress to date","volume":"22","author":"Correale","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0025","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/erv.09.77","article-title":"DNA vaccines in veterinary use","volume":"8","author":"Redding","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/gm15","article-title":"A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans","volume":"1","author":"Frelin","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00253-009-1889-8","article-title":"Engineering of bacterial strains and vectors for the production of plasmid DNA","volume":"82","author":"Bower","year":"2009","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jbiosc.2010.06.008","article-title":"Plasmid DNA of high quality purified by activated charcoal","volume":"110","author":"Kim","year":"2010","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biotechadv.2009.02.003","article-title":"Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production","volume":"27","author":"Williams","year":"2009","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0050","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ajic.2006.05.238","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae","volume":"34","author":"Paterson","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0055","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.vaccine.2010.03.040","article-title":"Biosafety of DNA vaccines: new generation of DNA vectors and current knowledge on the fate of plasmids after injection","volume":"28","author":"Faurez","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0378-1119(85)90076-9","article-title":"Cloning of a DNA sequence that complements glutamine auxotrophy in Saccharomyces cerevisiae","volume":"36","author":"Gonz\u00e1lez","year":"1985","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0065","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1093\/nar\/29.5.e26","article-title":"Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration","volume":"29","author":"Cranenburgh","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/biot.200700141","article-title":"A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy","volume":"3","author":"Mairhofer","year":"2008","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0075","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.vaccine.2009.06.017","article-title":"Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system","volume":"27","author":"Luke","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1472-6750-8-61","article-title":"Plasmid selection in Escherichia coli using an endogenous essential gene marker","volume":"8","author":"Goh","year":"2008","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0085","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1074\/jbc.274.16.11110","article-title":"Mechanism of triclosan inhibition of bacterial fatty acid synthesis","volume":"274","author":"Heath","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/01652176.2007.9695228","article-title":"Bovine viral diarrhoea virus (BVDV) diversity and vaccination. A review","volume":"29","author":"Kalaycioglu","year":"2007","journal-title":"Vet Quart."},{"key":"10.1016\/j.vaccine.2011.12.078_bib0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.20506\/rst.25.3.1703","article-title":"The control of bovine viral diarrhoea virus in Europe: today and in the future","volume":"25","author":"Lindberg","year":"2006","journal-title":"Rev Sci Tech Off Int Epizoot"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0100","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.vaccine.2009.02.010","article-title":"Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus","volume":"27","author":"Thomas","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-1135(00)00238-8","article-title":"Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus","volume":"76","author":"Nobiron","year":"2000","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0110","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/S0264-410X(01)00157-8","article-title":"Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice","volume":"19","author":"Nobiron","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0115","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0264-410X(02)00745-4","article-title":"DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge","volume":"21","author":"Nobiron","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0120","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1021\/jf0632841","article-title":"Measurement of triclosan in water using a magnetic particle enzyme immunoassay","volume":"55","author":"Shelver","year":"2007","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0125","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/es702300s","article-title":"Selective enzyme-linked immunosorbent assay for triclosan. Application to wastewater treatment plant effluents","volume":"42","author":"Brun","year":"2008","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.45.2.428-432.2001","article-title":"Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ","volume":"45","author":"Chuanchuen","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JCM.42.1.73-78.2004","article-title":"Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents","volume":"42","author":"Braoudaki","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0140","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/jac\/dkm314","article-title":"Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness","volume":"60","author":"Karatzas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1365-2672.2003.02022.x","article-title":"Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers","volume":"95","author":"Cole","year":"2003","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0150","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1128\/AEM.69.9.5433-5442.2003","article-title":"Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility","volume":"69","author":"McBain","year":"2003","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0155","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.envint.2010.02.001","article-title":"Predicted no effect concentration (PNEC) for triclosan to terrestrial species (invertebrates and plants)","volume":"36","author":"Amorim","year":"2010","journal-title":"Environ Int"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0165","first-page":"28","article-title":"Functional analysis of antibody responses of feedlot cattle to bovine respiratory syncytial virus following vaccination with mixed vaccines","volume":"61","author":"West","year":"1997","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2011.12.078_bib0170","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/BF01718248","article-title":"Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease","volume":"141","author":"Bolin","year":"1996","journal-title":"Arch Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T01:42:30Z","timestamp":1588815750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11020275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11020275"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}